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ABSTRACT
In this study we used proteomics approaches to obtain the protein profile of human epileptic hippocampi (N=6) 
and control hippocampi obtained from autopsy (N=6).  We used two-dimensional gel electrophoresis (2-D) 
coupled to HPLC and Mass spectroscopy (MALDI-TOF) to identify proteins differentially expressed. Nine 
proteins were differentially expressed comparing the hippocampus of patients with the hippocampus of control. 
Proteins that were increased in the hippocampus of patients with TLE were: isoform 1 of serum albumin, HSP 70, 
dihydropyrimidinase-related protein 2, isoform 1 of myelin basic protein, proton ATPase catalytic subunit A, and 
dihydrolipoyllysine-residue acethyltransferase component of pyruvate dehydrogenase complex. The expression 
of isoform 3 of spectrin alpha chain (fodrin) was down-regulated while the proteins glutathione S-transferase 
P and the DJ-1 (PARK7) were detected only in the hippocampus of patients with TLE. Taken together, our 
results provide evidence supporting a direct link between metabolic disturb and oxidative damage related 
to pathophysiology of TLE. Besides, indicates biomarkers for further investigations as therapies targeted to 
epilepsy.
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RESUMO
Perfil proteômico hipocampal em epilepsia do lobo temporal
No presente estudo empregou-se o método de proteômica para obter a expressão diferencial de proteínas em 
hipocampo de pacientes com epilepsia do lobo temporal (ELT) (N=6) comparado a hipocampos controle 
obtidos por meio de autópsia (N=6). O estudo foi feito  por meio de eletroforese bidimensional, acoplada a 
HPLC e espectroscopia de massa. As proteínas que tiveram expressão aumentada no hipocampo de pacientes 
com ELT foram: isoforma-1 da soroalbumina, HSP70, diidropirimidinase-2, isoforma-1 da proteína básica da 
mielina, subunidade catalítica A da próton ATPase, glutationa S-transferase P, proteína DJ-1 (PARK7), e 
resíduo diidropolilisina do componente acetil-transferase do complexo da piruvato desidrogenase. A expressão 
da isoforma-3 da cadeia alfa da espectrina (fodrina) foi menor no hipocampo de pacientes com epilepsia do lobo 
temporal e as proteínas glutationa S-transferase P e PARK7 foram detectadas somente no tecido epiléptico. 
Assim, nossos resultados trazem evidencias sobre a direta relação entre distúrbio metabólico e dano oxidativo 
na patofisiologia da ELT. Além disto, o estudo indica biomarcadores para futuras investigações como alvos 
terapêuticos para epilepsia.
Palavras-chave: epilepsia do lobo temporal, hipocampo, proteômica, biomarcadores.
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BACKGROUND AND PURPOSE
Epilepsy is a chronic disorder characterized by repeated 
seizures resulting from abnormal activation of neurons in 
the brain. There are some studies analyzing gene expression 
in epilepsy. However there is a lack of studies evaluating the 
regulation of the gene expression, in post-transcriptional or 
post-translational level, and these data are very important 
to elucidate the identify proteins which are involved in 
the pathophysiology of epilepsies. We have used proteomic 
approaches to investigate the expression of soluble 
proteins in the hippocampi of patients with temporal lobe 
epilepsy.
MATERIAL AND METHODS
Human tissue
All experiments were performed under approval from 
the Institutional Ethics Committee of the Universidade 
Federal de São Paulo (UNIFESP). Patients with intractable 
epilepsy were submitted to standard cortico-amygdalo-
hippocampectomy at the Hospital of São Paulo (UNIPETE/
SPDM-UNIFESP). Selected patients (N=6) had detailed 
anamnesis, video-EEG recordings and MRI studies and after 
these procedures the epileptogenic zone was delineated. 
Control hippocampi were obtained from brains showing 
no evidence of pathology on the basis of gross and routine 
histological examination removed from autopsies made by 
a pathologist from Dept. Pathology, Incor/FMUSP.
Sample preparation
Hippocampi were mixed with homogenization 
buffer consisting of 7M urea, 2M thiourea, 4% (w/v) 
CHAPS, 10 mM DTT, 1mM EDTA, 1mM PMSF, 
0.2mM Na2VO3 and 1mM NaF. After sonication on an 
ice bath, the suspension was centrifuged at 12000 × g for 
40 min at 4oC. The protein content of the supernatant was 
determined by using the Bradford method.
Two-dimensional gel electrophoresis (2-DE)
Five hundred micrograms of protein from each sample 
were used for 2-DE. 17 cm linear pH 3-10 IPG strips 
(BioRad Laboratories, Hercules CA, USA) were used for 
the first dimension. Isoeletric focusing was performed by 
using a Protean IEF cell (BioRad Laboratories, Hercules, 
CA, USA). Focusing was started at 100 V, and after the 
voltage was gradually increased to 8 kV in a linear mode 
during 150 min and, finally, 8.000 V was applied until 45 
kVh was reached. The equilibrated strips were then placed 
onto second dimension 12% SDS-PAGE gels. The SDS-
PAGE was conducted in a standard Tris-Glycine-SDS 
buffer in Protean II xi Cell (BioRad Laboratories, Hercules, 
CA, USA) at a constant current setting of 20 mA/gel for 
1h, then at 60 mA/gel until the end. Gels were stained by 
Coomassie method (Candiano et al., 2004).
Image analysis and determination of 
proteome differences
Stained gels were scanned by a GS-800 calibrated 
densitometer (BioRad Laboratories, Hercules, CA, USA) 
and PDQuest 2D-gel analysis software (Version 8.0.1, 
BioRad Laboratories, Hercules, CA, USA) was used to match 
and analyze visualized protein spots among differential gels 
in order to compare protein content between TLE samples 
and control (N=6/group). Normalized density values were 
used for comparisons, and spots exhibiting at least 2 fold 
increases or decreases were identified by mass spectrometry. 
In-gel digestion
Excised protein spots were subjected to in-gel trypsin 
digestion for 20 min at room temperature. The reaction was 
stopped by adding 50 μl of a solution of trifluoroacetic acid 
(TFA) at 0.1%. The samples were dehydrated in a vacuum 
centrifuge and resuspended in 0.1% TFA until ready to be 
applied to LC-ESI-MS/MS analysis.
Nano-LC-ESI-MS/MS analysis
An aliquot (4.5 μl) of digested proteins was inject 
by analytic column C18, 1.7 μm, BEH 130 RP-UPLC 
(nanoAcquity UPLC, Waters) coupled with nano-
electrospray tandem mass spectrometry on a Q-Tof Ultima 
API mass spectrometer (MicroMass/Waters). The gradient 
was 0-50% acetonitrile in 0.1% formic acid over 45 min. 
Databases searches for peptide identification from LC 
MS-MS experiments were done with Mascot Distiller 
v.2.3.2.0, 2009 (Matrix Science, Boston, MA) using 
carbamidomethyl-cys as fixed modification, lysine and/
or arginine methylation, lysine acetylation, methionine 
and/or tryptophan oxidation as variable modification 
and 0.1Da MS and MS/MS fragment tolerances. Proteins 
were identified by searching a Homo sapiens protein 
database.
STATISTICS
All data were presented as means ±SD and analyzed 
by Student’s t-test. Statistical significance was defined as 
p<0.05.
RESULTS
In total, twelve 2-DE gels corresponding to 6 patients 
and 6 controls were analyzed simultaneously and matched 
in the same set. We detected approximately 192-269 spots in 
each gel. The image analysis revealed 215±21 spots in the 
patients, and 237±32 in the control. When 2-DE patterns 
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Table 1. Protein differentially expressed in the hippocampus of patients with TLE.
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Figure 2. Two-dimensional 
gel electrophoresis analysis 
for the validation of protein 
expression differences between 
control and TLE groups. 
In A: up-regulated spots in the 
TLE are shown as filled arrows 
(6), marked with dotted arrows 
are the spots detected only 
in the control group (5), and 
marked with arrows with square 
tip are the spots up-regulated 
in the control group (2). 
In B: marked with arrows are 
the spots detected only in the 
epileptic group (3). Significance: 
≥2 fold change, t-test, p<0.05. 
of the groups were compared 16 spots were differentially 
expressed between control and epileptic groups. 
The Figure 2 describes unique and overlapping 
proteins with significant difference between the groups. In 
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Figure 1. Two-dimensional gel electrophoresis patterns of 
hippocampus of control (A) and TLE (B) groups (N=6/group).
the epileptic group 6 spots were up-regulated and 3 were 
present only in this group. In the control group 2 spots were 
up-regulated and 5 were found only in this group. 
As shown in Table 1, a total of nine distinct proteins 
were finally identified with ESI-Q-TOF MS and MS/
MS analysis. Identified proteins were: isoform 1 of 
serum albumin, HSP 70, dihydropyrimidinase-related 
protein 2, isoform 1 of myelin basic protein, isoform 3 of 
Spectrin alpha chain, proton ATPase catalytic subunit A, 
glutathione S-transferase P, protein DJ-1 (PARK7), and 
dihydrolipoyllysine-residue acetyltransferase component 
of pyruvate dehydrogenase complex. The expression of 
Spectrin was down-regulated in the hippocampi of patients 
with temporal lobe epilepsy. Glutathione S-transferase 
P and PARK7 were detected only in epilepsy. All other 
proteins were up-regulated in epilepsy. Table 2 shows the 
principal cellular and molecular functions related to the 
identified proteins.
IP Protein name MW Changes
5.92 Isoform 1 of Serum albumin – ALB 71317
5.56 Heat shock-related 70 kDa protein 2 – HSPA2 70263
8.2 Dihydropyrimidinase-related protein 2 – DPYSL2 77912
9.79 Isoform 1 of Myelin basic protein – MBP 33097
5.21 Isoform 3 of Spectrin alpha chain, brain – SPTAN1 282906
5.35 V-type proton ATPase catalytic subunit A – ATP6V1A 68660
5.43 Glutathione S-transferase P – GSTP1 23569 +
6.33 Protein DJ-1 – PARK7 20050 +
7.96 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial – DLAT 69466
MW: molecular weight; IP: isoelectric point.
All identifications met statistical confidence criteria according to MASCOT and NCBI scoring schemes (p<0.05).
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CONCLUSIONS
Taken together, our results provide evidence supporting 
a direct link between metabolic disturb and oxidative 
damage to the pathology of TLE. Besides, indicates 
biomarkers for further investigations as therapies targeted at 
epilepsy. The DPYSL2 a protein that is up-regulated in the 
hippocampus of epileptic patients with pharmacoresistant 
seizures has been associated with psychiatric disorder such 
as schizophrenia. Further studies are needed to elucidate 
whether this protein represent a link between TLE and 
psychiatric disorder or is only an independent mechanism. 
Reduction in fodrin expression is other important data 
from this study. Fodrin plays an important role in anchoring 
NMDA receptors in the membrane and disturbances in 
the expression of this protein may cause changes in the 
electrophysiological functioning of the receptor.
Table 2. Cellular and molecular functions of identified proteins.
Protein name Function
Isoform 1 of Serum albumin – ALB Regulation of the colloidal osmotic pressure of blood. 
Major zinc transporter in plasma.
Heat shock-related 70 kDa protein 2 – HSPA2 Chaperone.
Dihydropyrimidinase-related protein 2 – DPYSL2 Necessary for the remodeling of the cytoskeleton after injury. 
Plays a role in axon guidance, neuronal growth cone collapse and cell migration.
Isoform 1 of Myelin basic protein – MBP Strutural constituent of myelin sheath. It has a role in both its formation and stabilization. 
The smaller isoforms might have an important role in remyelination of denuded axons in 
multiple sclerosis.
Isoform 3 of Spectrin alpha chain, brain – SPTAN1 Interacts with calmodulin in a calcium-dependent manner. 
Candidate for the calcium-dependent movement of the cytoskeleton at the membrane.
V-type proton ATPase catalytic subunit A – ATP6V1A Responsible for acidifying a variety of intracellular compartments in eukaryotic cells. 
It may participate in maintenance of cytoplasmic Ca2+ homeostasis.
Glutathione S-transferase P – GSTP1 Conjugation of reduced glutathione to exogenous and endogenous hydrophobic 
electrophiles.
Protein DJ-1 – PARK7 Protects cells against oxidative stress and cell death.
Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial – DLAT
Catalyzes the overall conversion of pyruvate to acetyl-CoA and CO2. 
It contains multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), 
dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3).
The function of each protein was identified using the UniProt database.
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